ElendiLabs Logo
Back to Articles

Need Regulatory Help? Try Our Platform

Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.

Registration

May 17, 2025

Approximately 5 minutes

Software Medical Devices and Cybersecurity in Hong Kong: A Guide to TR-007

Infographic: Software Medical Devices & Cybersecurity in Hong Kong – Guide to TR-007 (MDACS). Covers TR-007 overview, types (SaMD standalone, SiMD in hardware), cybersecurity requirements (risk management, updates, monitoring), responsibilities (manufacturers/LRP), and patient safety benefits.

Safeguarding Digital Health: Software Medical Devices and Cybersecurity in Hong Kong – Our Insights

From our perspective, the rapid growth of digital health has put software at the very heart of medical innovation. In Hong Kong, the Medical Device Administrative Control System (MDACS) clearly recognizes the unique regulatory challenges and safety concerns that software brings. Technical Reference TR-007, specifically titled "Software Medical Devices and Cybersecurity," provides essential guidance for manufacturers and Local Responsible Persons (LRPs) on how to classify, develop, and protect the cybersecurity of software that acts as a medical device.

To our understanding, TR-007 aims to make sure that software medical devices are safe, work exactly as they're supposed to, and are well-protected against cyber threats. This document reflects global best practices in this constantly evolving field, which is crucial for Hong Kong medical device cybersecurity.


What are Software Medical Devices? Understanding SaMD and SiMD

TR-007 clearly explains the difference between two main types of software we see in the medical world. Have you ever wondered if a health app on your phone counts as a medical device? Let's clarify!

  1. Software as a Medical Device (SaMD):

    • This is software that fits the definition of a medical device and is designed to be used for one or more medical purposes without being built into a piece of hardware medical equipment.
    • According to our experience, SaMD performs its medical function all by itself. Common examples include software for analyzing medical images (like X-rays), programs that help plan treatments, or even mobile apps that give medical diagnoses based on user input. This is a growing area in digital health Hong Kong.
  2. Software in a Medical Device (SiMD):

    • This is software that's an essential part of a hardware medical device. It's needed for that piece of equipment to do its intended medical job.
    • What's the key difference? SiMD can't work as a medical device on its own if it's separated from the hardware. Think of the operating software built inside an MRI scanner or the program that controls an infusion pump – these are prime examples.

How Are Software Medical Devices Classified?

The way SaMD and SiMD are classified under MDACS follows the same risk-based principles as other medical devices (you can find details in TR-003 for general devices and TR-006 for IVDMDs). The risk class depends on factors like what the software is intended to be used for, how important the information it provides is for diagnosis or treatment, and the potential impact on a patient's health if the information is wrong. TR-007 provides specific considerations and helpful flowcharts to guide you in correctly classifying your software, which is a critical step for software medical device regulation in Hong Kong.


Cybersecurity: Why It's Absolutely Crucial for Medical Devices

Why is cybersecurity such a big deal for software medical devices? Because they can be vulnerable to unauthorized access, changes, or even being shut down, which could directly affect patient safety and the privacy of their sensitive health data. TR-007 strongly emphasizes that manufacturers must build cybersecurity measures into every single stage of their software medical devices' lifespan. Key cybersecurity requirements, as we understand them, include:

  1. Risk Management:
    • Manufacturers absolutely must perform thorough cybersecurity risk assessments. This means identifying any known weaknesses and potential threats.
    • This includes making sure patient data stays intact, confidential, and always available when needed.
  2. Secure Design and Development:
    • Implementing safe coding practices and designing the software's architecture in a way that minimizes vulnerabilities.
    • Addressing threats like unwanted access, data tampering, and malicious software.
    • According to our experience, thinking about how users will log in (e.g., strong passwords, multi-factor authentication) from the start is vital.
  3. Vulnerability Management:
    • Setting up a system to manage how vulnerabilities are reported and actively keeping an eye out for new threats.
    • Developing clear procedures for applying timely software patches and updates to fix any identified weaknesses.
  4. Post-Market Surveillance and Monitoring:
    • Proactively monitoring the device's cybersecurity status once it's being used by patients or in clinics.
    • Putting in place ways to detect anything unusual or inconsistent in how the device operates or its data.
    • For software that uses Artificial Intelligence (AI) or Machine Learning (ML), it's important to address potential "concept drift" (where the AI's understanding changes over time) and ensure data integrity. This is a complex but growing area in AI medical devices Hong Kong.
  5. Documentation:
    • Providing clear, comprehensive paperwork about all the cybersecurity measures you've put in place. This includes cybersecurity plans, risk analyses, and reports proving your security works.
    • To our understanding, this documentation becomes part of your STED dossier (TR-002) when you submit for listing.
  6. Software Version Control and Traceability:
    • Making sure that the software versions you describe in your pre-market submissions clearly match the versions you actually sell.
    • Establishing strong processes for managing frequent software updates, including having options to revert to older versions if needed.

Manufacturer's and LRP's Responsibilities: Who Does What?

Manufacturers are ultimately responsible for making sure their software medical devices meet all the necessary basic principles and cybersecurity requirements. The Local Responsible Person (LRP) plays a crucial role in making sure this compliance is met, especially for foreign manufacturers. Based on our knowledge, the LRP must ensure that all the technical documentation accurately reflects strong cybersecurity practices, and that any cybersecurity issues that pop up after the product is on the market are quickly resolved and reported to the MDD. This continuous vigilance is vital for medical device regulatory compliance.

TR-007, in our opinion, serves as an indispensable guide. It helps ensure that we can fully enjoy the benefits of exciting software innovations in healthcare without ever compromising patient safety or the security of their sensitive data in Hong Kong.

Ask Anything

We'll follow up with you personally.

100% response rate • Reply within 7 business days

Your email will not be published. We'll only use it to notify you when we respond.

Questions & Answers (3)

A
Guest

我们已有一个旧版的软件表列号,但计划在 2026 年 2 月发布大版本更新(包含重大算法变更)。鉴于 Stage C 采购节点 在 3 月 23 日到期,我们应该申请‘变更 (Change Application)’还是重新注册?如果更新未能在截止日前获批,医院管理局 (HA) 的老用户能否继续使用旧版?

ElendiLabs

算法变更为“重大变更”,需通过 GN-10 路径申请。 • 时效策略: 考虑到 2026 年初 MDD 的处理积压,建议立即提交变更申请。在获批前,原有的 HKMD 编号在系统中仍视为有效,但仅限旧版本。 • Stage C 风险: 若要在 3 月后参与新标,必须确保新版本的变更已被 MDD 记录并更新在 MDIS 证书上,否则将被视为不合规。

A
Guest

我们有一款基于云端的 AI 影像辅助诊断软件,已获美国 FDA 510(k) 许可。根据 2025 年修订版 TR-007,由于它涉及 AI 算法且在云端运行,其网络安全风险是否会自动将其分类等级从 Class II 提升至 Class III?在提交时,我们需要如何处理 TR-007 与 TR-008 的合规重叠

ElendiLabs

分类主要基于临床意图而非技术架构。但 TR-007 明确指出,如果网络安全漏洞可能导致错误的诊断结论并危及生命,分级会趋严。 • 重叠处理: 您需要提交一份合并的技术文件。在 TR-008 框架下,重点说明算法的透明度与数据集(Training/Validation/Test)的本地相关性;在 TR-007 下,重点说明云端数据传输的加密(AES-256)与身份验证机制。2026 年的 MDIS 系统要求必须同时勾选“AI 驱动”与“网络安全相关”两个标识。

A
Guest

我们的 SaMD 数据存储在 AWS 新加坡节点。在 2026 年的注册审核中,卫生署医疗器械分部 (MDD) 是否强制要求数据必须物理存储在香港境内?对于跨境传输医疗数据,LRP 是否需要向私隐专员公署 (PCPD) 备案?

ElendiLabs

香港目前并不强制要求数据本地化存储,但必须严格遵守 PDPO 的六项原则。 • 合规要求: 建议在技术文件中证明采取了“所有务实步骤”保护数据(DPP 4)。这包括与云供应商签订符合香港法律的数据处理协议 (DPA)。 • 备案建议: 虽然无需强制向 PCPD 备案,但 LRP 建议持有隐私影响评估 (PIA) 报告,以备 MDD 在 2026 年加强的现场审核中抽查。

Need Expert Guidance?

Contact us at contact@elendilabs.com / +852 4416 5550